Cargando…

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence

OBJECTIVE: The study aims to assess the cardiovascular safety of growth hormone (GH) treatment in patients with Noonan syndrome (NS) in clinical practice. DESIGN: The study design involves two observational, multicentre studies (NordiNet® IOS and the ANSWER Program) evaluating the long-term effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romano, Alicia, Kaski, Juan Pablo, Dahlgren, Jovanna, Kelepouris, Nicky, Pietropoli, Alberto, Rohrer, Tilman R, Polak, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859970/ https://www.ncbi.nlm.nih.gov/pubmed/34939937 http://dx.doi.org/10.1530/EC-21-0549

Ejemplares similares

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
por: Jorge, Alexander A L, et al.
Publicado: (2022)

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER
por: Sävendahl, Lars, et al.
Publicado: (2021)

Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2022)

Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis
por: Ross, Judith, et al.
Publicado: (2023)

LBMON197 Predictors Of Response To Growth Hormone Treatment In Pediatric Growth Disorders: Analysis From The Answer Program And Nordinet® IOS
por: Ross, Judith L, et al.
Publicado: (2022)

Effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age: Long-Term Data From NordiNet® International Outcome Study (IOS) and ANSWER Program
por: Juul, Anders, et al.
Publicado: (2021)

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet(®) IOS and Answer Program
por: Backeljauw, Philippe, et al.
Publicado: (2023)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study
por: Angulo, Moris, et al.
Publicado: (2020)

Abstract 2: Effectiveness and safety of early growth hormone treatment in children born small for gestational age: Long-term data from NordiNet® International Outcome Study (IOS) and ANSWER program
por: Ranjan, K M, et al.
Publicado: (2022)

Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age
por: Juul, Anders, et al.
Publicado: (2022)

Mutation in NRAS in familial Noonan syndrome – case report and review of the literature
por: Ekvall, Sara, et al.
Publicado: (2015)

Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet(®) IOS and ANSWER Program
por: Sävendahl, Lars, et al.
Publicado: (2019)

Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment
por: Carcavilla, Atilano, et al.
Publicado: (2023)

Growth hormone therapy in patients with Noonan syndrome
por: Seo, Go Hun, et al.
Publicado: (2018)

Effectiveness of growth hormone therapy in children with Noonan syndrome
por: Seok, Eun mi, et al.
Publicado: (2020)

Tegumentary manifestations of Noonan and Noonan-related syndromes
por: Quaio, Caio Robledo D'Angioli Costa, et al.
Publicado: (2013)

Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet® International Outcome Study
por: Polak, Michel, et al.
Publicado: (2017)

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome
por: Vurallı, Doğuş, et al.
Publicado: (2016)

Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome
por: Sun, Ling, et al.
Publicado: (2022)

Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review
por: Nugent, Diane J, et al.
Publicado: (2018)

Noonan syndrome
por: van der Burgt, Ineke
Publicado: (2007)

Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency
por: Zavras, Niki, et al.
Publicado: (2015)

Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome
por: Shin, Young-Lim
Publicado: (2019)

Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study
por: Apperley, Louise Jayne, et al.
Publicado: (2020)

Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
por: Libraro, Annachiara, et al.
Publicado: (2021)

THU008 Coverage Of Education And Training Of Traumatic Brain Injury-induced Growth Hormone Deficiency In US Endocrinology Fellowship Programs
por: Ji Yuen, Kevin Choong, et al.
Publicado: (2023)

Transcriptional Hallmarks of Noonan Syndrome and Noonan-Like Syndrome with Loose Anagen Hair
por: Ferrero, Giovanni Battista, et al.
Publicado: (2012)

Management of Cardiovascular Disorders in Patients with Noonan Syndrome: A Case Report
por: Khorgami, Mohammad Rafie, et al.
Publicado: (2017)

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective
por: Hoffman, Andrew R, et al.
Publicado: (2022)

The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children
por: Kriström, Berit, et al.
Publicado: (2009)

Clinical manifestations of Noonan syndrome
por: Digilio, MC, et al.
Publicado: (2001)

Recognition Memory in Noonan Syndrome
por: Costanzo, Floriana, et al.
Publicado: (2021)

SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience
por: Wajnrajch, Michael, et al.
Publicado: (2019)

Differences in severity of cardiovascular anomalies in children with Noonan syndrome based on the causative gene
por: Shehade-Awwad, Nagham, et al.
Publicado: (2022)

Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
por: Jo, Kyo Jin, et al.
Publicado: (2019)

Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children
por: Decker, Ralph, et al.
Publicado: (2012)

A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature
por: Hellgren, Gunnel, et al.
Publicado: (2008)

The other side of Turner's: Noonan's syndrome
por: Agarwal, Pankaj, et al.
Publicado: (2013)

Noonan syndrome – a new survey
por: Tafazoli, Alireza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ndnrc6friaidu97ivjrrhguurv